A view from the Center

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

The next generation of scientists are digital natives ready to problem solve and innovate

by Juergen A. Klenk, Ph.D, Principal, Deloitte Consulting LLP

This week Deloitte and the National Institutes of Health’s National Library of Medicine (NLM) will recognize two student-led research teams from San Diego State University (SDSU) and Kingsborough Community College of The City University of New York (KCC CUNY) for their groundbreaking research in the Microbial Metagenomics Discovery Challenge.

The undergraduate students’ work was impressive by any standard.

Read more

From center ice to the operating room: AR/VR technologies could transform consumer, clinician, and patient experiences

by Shantaram (Shaun) Rangappa, MD, MSHA, Managing Director, Deloitte Consulting LLP

I live outside of Washington, D.C., and I was thrilled to see the Washington Capitals advance to the Stanley Cup finals for the first time in 20 years. I always enjoy watching sports on TV, but the experience has changed little since sports became televised. Now imagine donning an immersive experience headset and watching a championship game from center ice…with players gliding all around you.

Read more

A New Frontier for research: Liftoff for the All of Us study

by Margaret Anderson, Managing Director, Deloitte Consulting LLP

This week, we will witness liftoff for a new National Institutes of Health (NIH) initiative that strives to move our current state of research to a future state of precision medicine where data is broken out of siloes. Researchers will have novel opportunities to study the data, which could speed medical breakthroughs.

I’ve had the privilege of seeing the All of Us Research Program grow from a kernel of an idea into a path-breaking program that ambitiously aims to gather data from 1 million or more diverse people—healthy and sick—living in the US.

Read more

Costs, shortages prompt some hospitals to consider generic-drug manufacturing

by Faith Glazier, Principal, Deloitte Consulting LLP

Four of the nation’s largest hospital systems—Ascension, Intermountain Healthcare, SSM Health, and Trinity Health—are looking into manufacturing some of their own generic drugs, according to recent news reports. At this point, it’s not entirely clear what is driving this decision, but I suspect rising drug costs and/or shortages are likely two big factors.

Based on recent conversations with industry executives,

Read more

Early-stage medtech venture investment is up, driven by digitally-enabled diagnostics. But is the market ready?

by Sonal Shah, Senior Manager, Deloitte Center for Health Solutions, Deloitte Services LP

In my role with the Center for Health Solutions, I spend a fair amount of time researching technology and exploring the impact new medical devices could have on the health care sector. I generally don’t get much first-hand experience with medical devices. That recently changed.

When I told my primary care doctor about some odd sensations I had been feeling in my chest,

Read more